Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Officials of Paonta Sahib regional office of the State Pollution Control Board (SPCB) today collected samples of waste water of a pharmaceutical unit following complaints by local villagers that the effluents released by the unit were causing pollution in the vicinity. The said pharmaceutical unit is already under the scanner …
Forget laymen, even doctors don't get adequate information about the drugs they prescribe for their patients. Drug companies advertise prescription drugs in medical journals to boost sales, but a majority of them don't give doctors vital information such as adverse effects the medicines can have with other drugs, according to …
In the race to develop an Ebola vaccine, a small cancer therapy company, NewLink Genetics, has been in the shadows of GlaxoSmithKline (GSK), a big pharma company with lots of experience and far deeper resources. But at a high-level meeting held by the World Health Organization on 23 October, it …
Even as deadly Ebola continues to spread its wings, pharmaceutical companies developing the vaccines are committed to ramp up production capacity for millions of doses to be available in 2015. According to the World Health Organisation (WHO), trials of vaccines have already begun in the US, the UK, and Mali …
A high-level emergency meeting, convened by the World Health Organization at the request of several governments and representatives of the pharmaceutical industry, was held on 23 October to look at the many complex policy issues that surround eventual access to experimental Ebola vaccines. Ways to ensure the fair distribution and …
Bedaquiline, the first anti-tuberculosis (TB) drug manufactured in almost 50 years, not only worked on severely ill patients in the city but it did so without affecting their hearts. An article to this effect was published in the International Journal of Tuberculosis and Lung Disease last week, showing “drastic“ improvement …
The Ministry of Health and Family Welfare has banned the use of plastic containers for primary packaging of drugs. The ministry has issued a draft notification on September 29 to invite objections and suggestions from the pharmaceutical industry within 45 days after which a final notification will be issued, banning …
India has strongly objected to the findings of new research that raises questions about the quality of drugs manufactured in the country and exported abroad.
Researchers with financial ties to flu drug companies more often reported positive findings in their studies of the treatments, a new analysis found. Seven of eight studies that analyzed previous research and whose researchers had financial ties to the drug industry were considered favorable to the flu treatments, including Roche …
The pharmaceutical market in India is unique in that it is dominated by "branded" generics which enjoy a price premium though they are not superior to "unbranded" generics in either pharmacopoeia or therapeutic value. Aggressive marketing of branded generics has led to higher prices, irrational fixed dose combinations and concentration …
In a significant move, the government has decided to waive off local clinical trials in case of new drugs indicated for serious, life-threatening diseases and diseases of special relevance to Indian health scenario like cancer, AIDS etc., where the likelihood of death is high. Observing that in cases of life-threatening …
Believed To Cure 90% Of Patients Even as a controversy rages globally over the eye-popping price of US firm Gilead Science’s hepatitis C drug at $1,000 a pill, Indian patients have already begun importing the medicine from countries like Canada, spending, in some cases, up to Rs 1 crore. The …
Implementing patient cost sharing in the form of copayments, coinsurance, and deductibles is one of the more reliable methods for reducing health care costs. But imposing cost sharing reduces patients' demand for medical care, which sets the interests of insurers at odds with the interests of health care providers and …
Wants cos to ensure early launch of new therapies here if trials prove successful This move is part of steps DCGI has taken last week to bring clarity in the clinical trials space and ensure patients are not exploited Multinational pharmaceutical companies keen to conduct clinical trials for new drugs …
Pharmaceutical companies tend to highlight their role in saving lives, but say little about the impact their manufacturing processes might have on public health and the environment. Addressing that issue is at the heart of Phil Dahlin’s role as director of sustainability for Janssen, the pharmaceuticals arm of Johnson & …
In The Lancet, findings from Nita Bhandari and colleagues' phase 3 clinical trial1 show the safety and efficacy of the 116E rotavirus vaccine against severe rotavirus gastroenteritis in Indian infants. The vaccine has an efficacy similar to that of two licensed oral rotavirus vaccines—RotaTeq (Merck) and Rotarix (GlaxoSmithKline)—when tested in …
Hope Hinges On Drugs Mimicking Effects Of Mutations That Cripple APOC3 Four rare mutations in a single gene may reduce the risk of heart disease by 40%, a new study has found. By scouring the DNA of thousands of patients, researchers at the Broad Institute, Massachusetts General Hospital, and their …
Antibiotics now rank among the most counterfeited medicines in the world, feeding a global epidemic of drug-resistant superbugs. A new surveillance and reporting program in 80 countries led by the World Health Organization shows that counterfeit antibiotics are a growing problem in all regions of the world, rivaling fake versions …
